Sernova Corp. (SVA.TO)
CAD 0.23
(0.0%)
CAD 0.23
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -38.99 Million CAD | -58.92% |
| 2022 | -24.53 Million CAD | -249.36% |
| 2021 | -7.02 Million CAD | -29.89% |
| 2020 | -5.4 Million CAD | -35.92% |
| 2019 | -3.97 Million CAD | -7.57% |
| 2018 | -3.69 Million CAD | -40.13% |
| 2017 | -2.63 Million CAD | -5.6% |
| 2016 | -2.49 Million CAD | 12.58% |
| 2015 | -2.85 Million CAD | -4.13% |
| 2014 | -2.74 Million CAD | -37.1% |
| 2013 | -2 Million CAD | 22.01% |
| 2012 | -2.56 Million CAD | -27.34% |
| 2011 | -2.01 Million CAD | -9.23% |
| 2010 | -1.84 Million CAD | -25.74% |
| 2009 | -1.46 Million CAD | 46.67% |
| 2008 | -2.75 Million CAD | 23.35% |
| 2007 | -3.59 Million CAD | -185.74% |
| 2006 | -1.25 Million CAD | -189.96% |
| 2005 | -433.56 Thousand CAD | -17.7% |
| 2004 | -368.37 Thousand CAD | 48.11% |
| 2003 | -709.85 Thousand CAD | 52.55% |
| 2002 | -1.49 Million CAD | 30.08% |
| 2001 | -2.13 Million CAD | -406.99% |
| 2000 | -422.08 Thousand CAD | -1847.05% |
| 1999 | -21.67 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -9.74 Million CAD | 16.75% |
| 2024 Q3 | -7.53 Million CAD | 24.2% |
| 2024 Q2 | -9.94 Million CAD | -2.06% |
| 2023 Q4 | -11.7 Million CAD | -17.84% |
| 2023 Q2 | -9.28 Million CAD | -15.64% |
| 2023 Q3 | -9.93 Million CAD | -7.02% |
| 2023 Q1 | -8.02 Million CAD | 3.11% |
| 2023 FY | -38.99 Million CAD | -58.92% |
| 2022 FY | -24.53 Million CAD | -249.36% |
| 2022 Q3 | -5.84 Million CAD | -18.45% |
| 2022 Q1 | -5.45 Million CAD | -150.95% |
| 2022 Q2 | -4.93 Million CAD | 9.6% |
| 2022 Q4 | -8.28 Million CAD | -41.7% |
| 2021 FY | -7.02 Million CAD | -29.89% |
| 2021 Q1 | -1.49 Million CAD | -44.8% |
| 2021 Q3 | -1.63 Million CAD | 2.16% |
| 2021 Q4 | -2.17 Million CAD | -33.37% |
| 2021 Q2 | -1.66 Million CAD | -11.71% |
| 2020 Q2 | -1.73 Million CAD | -27.26% |
| 2020 Q1 | -1.36 Million CAD | 22.59% |
| 2020 Q4 | -1.03 Million CAD | 13.8% |
| 2020 Q3 | -1.19 Million CAD | 31.02% |
| 2020 FY | -5.4 Million CAD | -35.92% |
| 2019 Q3 | -874.75 Thousand CAD | -42.62% |
| 2019 Q1 | -723.75 Thousand CAD | 13.26% |
| 2019 FY | -3.97 Million CAD | -7.57% |
| 2019 Q4 | -1.75 Million CAD | -101.13% |
| 2019 Q2 | -613.35 Thousand CAD | 15.25% |
| 2018 Q1 | -766.35 Thousand CAD | 21.62% |
| 2018 FY | -3.69 Million CAD | -40.13% |
| 2018 Q4 | -834.36 Thousand CAD | 24.94% |
| 2018 Q3 | -1.11 Million CAD | -12.69% |
| 2018 Q2 | -986.35 Thousand CAD | -28.71% |
| 2017 Q2 | -638.43 Thousand CAD | -101.07% |
| 2017 Q1 | -317.52 Thousand CAD | -90.93% |
| 2017 FY | -2.63 Million CAD | -5.6% |
| 2017 Q4 | -977.73 Thousand CAD | -38.53% |
| 2017 Q3 | -705.79 Thousand CAD | -10.55% |
| 2016 Q3 | -964.94 Thousand CAD | -39.46% |
| 2016 Q4 | -166.3 Thousand CAD | 82.77% |
| 2016 FY | -2.49 Million CAD | 12.58% |
| 2016 Q1 | -676.45 Thousand CAD | 23.66% |
| 2016 Q2 | -691.91 Thousand CAD | -2.29% |
| 2015 Q4 | -886.11 Thousand CAD | -32.88% |
| 2015 Q2 | -676.21 Thousand CAD | -7.29% |
| 2015 Q3 | -666.85 Thousand CAD | 1.38% |
| 2015 Q1 | -630.29 Thousand CAD | 7.06% |
| 2015 FY | -2.85 Million CAD | -4.13% |
| 2014 Q3 | -745.83 Thousand CAD | 0.28% |
| 2014 FY | -2.74 Million CAD | -37.1% |
| 2014 Q4 | -678.18 Thousand CAD | 9.07% |
| 2014 Q2 | -747.93 Thousand CAD | -25.89% |
| 2014 Q1 | -594.1 Thousand CAD | -10.54% |
| 2013 Q4 | -537.44 Thousand CAD | -40.55% |
| 2013 Q2 | -551.7 Thousand CAD | -3.82% |
| 2013 Q1 | -531.38 Thousand CAD | 22.96% |
| 2013 FY | -2 Million CAD | 22.01% |
| 2013 Q3 | -382.39 Thousand CAD | 30.69% |
| 2012 FY | -2.56 Million CAD | -27.34% |
| 2012 Q1 | -625.83 Thousand CAD | -28.29% |
| 2012 Q4 | -689.73 Thousand CAD | -20.06% |
| 2012 Q2 | -677.97 Thousand CAD | -8.33% |
| 2012 Q3 | -574.48 Thousand CAD | 15.26% |
| 2011 Q1 | -521.65 Thousand CAD | -5.62% |
| 2011 FY | -2.01 Million CAD | -9.23% |
| 2011 Q4 | -487.81 Thousand CAD | -10.69% |
| 2011 Q3 | -440.7 Thousand CAD | 22.21% |
| 2011 Q2 | -566.56 Thousand CAD | -8.61% |
| 2010 FY | -1.84 Million CAD | -25.74% |
| 2010 Q2 | -425.6 Thousand CAD | 5.07% |
| 2010 Q3 | -478.49 Thousand CAD | -12.43% |
| 2010 Q4 | -493.9 Thousand CAD | -3.22% |
| 2010 Q1 | -448.36 Thousand CAD | 3.24% |
| 2009 Q2 | -384.08 Thousand CAD | -38.05% |
| 2009 FY | -1.46 Million CAD | 46.67% |
| 2009 Q3 | -342.67 Thousand CAD | 10.78% |
| 2009 Q4 | -463.37 Thousand CAD | -35.22% |
| 2009 Q1 | -278.22 Thousand CAD | 50.67% |
| 2008 Q1 | -623.17 Thousand CAD | 37.91% |
| 2008 Q4 | -564.06 Thousand CAD | -15.35% |
| 2008 FY | -2.75 Million CAD | 23.35% |
| 2008 Q3 | -488.99 Thousand CAD | 54.61% |
| 2008 Q2 | -1.07 Million CAD | -72.86% |
| 2007 Q4 | -1 Million CAD | 4.93% |
| 2007 Q3 | -1.05 Million CAD | 5.69% |
| 2007 Q1 | -413.3 Thousand CAD | -645.44% |
| 2007 Q2 | -1.11 Million CAD | -170.85% |
| 2007 FY | -3.59 Million CAD | -185.74% |
| 2006 Q4 | 75.77 Thousand CAD | 170.56% |
| 2006 FY | -1.25 Million CAD | -189.96% |
| 2006 Q2 | -1.12 Million CAD | -1046.42% |
| 2006 Q3 | -107.38 Thousand CAD | 90.47% |
| 2006 Q1 | -98.32 Thousand CAD | 16.07% |
| 2005 Q1 | -80.73 Thousand CAD | -210.26% |
| 2005 Q2 | -158.24 Thousand CAD | -96.0% |
| 2005 Q3 | -77.42 Thousand CAD | 51.07% |
| 2005 Q4 | -117.15 Thousand CAD | -51.32% |
| 2005 FY | -433.56 Thousand CAD | -17.7% |
| 2004 FY | -368.37 Thousand CAD | 48.11% |
| 2004 Q4 | 73.22 Thousand CAD | 175.53% |
| 2004 Q3 | -96.94 Thousand CAD | 41.08% |
| 2004 Q2 | -164.54 Thousand CAD | 8.65% |
| 2004 Q1 | -180.11 Thousand CAD | -86.09% |
| 2003 Q1 | -280.29 Thousand CAD | -16.04% |
| 2003 Q3 | -85.45 Thousand CAD | 65.45% |
| 2003 FY | -709.85 Thousand CAD | 52.55% |
| 2003 Q4 | -96.78 Thousand CAD | -13.26% |
| 2003 Q2 | -247.31 Thousand CAD | 11.76% |
| 2002 FY | -1.49 Million CAD | 30.08% |
| 2002 Q3 | -324.83 Thousand CAD | 30.52% |
| 2002 Q2 | -467.51 Thousand CAD | -1.14% |
| 2002 Q1 | -462.24 Thousand CAD | 0.0% |
| 2002 Q4 | -241.55 Thousand CAD | 25.64% |
| 2001 FY | -2.13 Million CAD | -406.99% |
| 2000 FY | -422.08 Thousand CAD | -1847.05% |
| 1999 FY | -21.67 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Appili Therapeutics Inc. | -3.78 Million CAD | -931.432% |
| Eupraxia Pharmaceuticals Inc. | -37.39 Million CAD | -4.295% |
| Helix BioPharma Corp. | -9.26 Million CAD | -320.958% |
| Microbix Biosystems Inc. | -39.48 Thousand CAD | -98670.408% |
| Medicenna Therapeutics Corp. | -25.46 Million CAD | -53.136% |
| Satellos Bioscience Inc. | -15.88 Million CAD | -145.437% |
| Oncolytics Biotech Inc. | -27.75 Million CAD | -40.521% |